Percutaneously Delivered Automated Continual Fluid Removal System in Patients With Advanced Diuretic-Resistant Heart Failure
NCT:NCT06689553 · TERMINATED
广告
NCT编号NCT06689553
状态TERMINATED
开始日期2025-09-28
完成时间2026-05-05
SponsorParagate Medical LTD (INDUSTRY)
First posted
Last updated
简要摘要
The study aims to assess the feasibility, safety, tolerability and functionality of a percutaneously delivered automated continual fluid removal System in up to 8 patients with Heart Failure (HF) and diuretic resistance. Intervention: Implanted absorption chamber, connected to an external pump. Follow up: 6 months post activation.
官方来源
在 ClinicalTrials.gov 上查看 →数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。